ARTICLE | Company News

AstraZeneca neurology news

August 16, 2010 7:00 AM UTC

AstraZeneca said it paid about $198 million to settle 17,500 product liability claims in the U.S. related to allegations of off-label marketing and promotions of Seroquel quetiapine. The pharma also said about 2,900 additional cases have been dismissed by order or agreement and that the only jury trial to date resulted in a verdict in favor of AstraZeneca. ...